$ASPI

ASP Isotopes (ASPI) reported that its Virginia gas project in South Africa has achieved stable liquid helium production, completing commissioning. The company's shares rose 7.2% in pre-market trading.

ASP Isotopes Inc. (ASPI) filed an SEC Form 8-K — Regulation FD Disclosure. EXHIBIT 99.1 ASP Isotopes Inc. Announces that Renergen Limited’s Virginia Gas Project has Achieved Stable Liquid Helium Production Phase 1 plant now in stable operation following commissioning; first liquid helium in storage ahead of initial deliveries to contracted offtakers DAL

ASP Isotopes subsidiary Quantum Leap Energy (QLE) signed a binding agreement with Necsa to form a joint venture for HALEU production at Pelindaba. QLE will hold 80% and lead operations. The venture aims to develop, finance, and operate test and commercial-scale facilities, with offtake agreements and initial approvals in place.

ASP Isotopes Inc. (ASPI) filed an SEC Form 8-K — Regulation FD Disclosure. EXHIBIT 99.1 Quantum Leap Energy and Necsa Sign Binding Heads of Agreement to Establish Joint Venture for HALEU Production in South Africa Joint Venture Supported by Offtake Agreements with TerraPower, Initial Regulatory Approvals, and Access to Site Infrastructure to enable QLE

ASP Isotopes Inc. (ASPI) filed an SEC Form 8-K — Regulation FD Disclosure. Item 7.01 . Regulation FD Disclosure. As previously disclosed, on June 25, 2026, ASP Isotopes Inc., a Delaware corporation (“ASPI” or the “Company”), entered into an Agreement and Plan of Merger (the “Merger Agreement”), by and among ENDRA Life Sciences Inc., a Delaware corporati

ASP Isotopes Inc. (ASPI) filed an SEC Form 8-K — Regulation FD Disclosure. EXHIBIT 99.1 ASP Isotopes Hosts Inaugural Capital Markets Day and Provides Operational Update DALLAS, Sept. 08, 2026 (GLOBE NEWSWIRE) — ASP Isotopes Inc. (NASDAQ: ASPI) ("ASP Isotopes" or the "Company"), an advanced materials company focused on developing technologies and process

ASP Isotopes Inc. (ASPI) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. On August 14, 2026, Renergen Limited (the “Borrower”), a wholly-owned subsidiary of ASP Isotopes Inc. (the “Company”), entered into a Second Amendment and Restatement Agreement (the “Second Amendment”) with The Standard Bank o

ASP Isotopes (ASPI) presented at the Emerging Growth Conference, outlining plans to commercialize projects in helium, isotopes, and nuclear fuel. CEO Paul Mann highlighted execution risks and supply shortages. The stock is down 73% from its 52-week high. The company aims to generate revenue and free cash flow over the next six months, with Phase 2 of its South African helium and LNG project fully funded. PET Labs reported 50% revenue growth in H1 2024, with expectations to double in 2026. The co

ASP Isotopes Inc. (NASDAQ: ASPI) announced that its subsidiary Renergen's Tetra4 has started commissioning a liquid helium plant in South Africa. Phase 1 expects to produce 70 Mcf/day of helium and 2,500 GJ/day of LNG, with commercial production starting in Q3 2026. Annual revenues are projected at over $27 million. Phase 2, 13 times larger, may begin construction in 2H 2026.

Simply Wall St reports ASP Isotopes (ASPI) shares fell 0.2% to about $4.27 after earnings. Q2 2026 revenue rose to $5.123M from $1.198M, while net loss narrowed to $33.585M from $75.062M and basic EPS loss improved to $0.27 from $1.03. The article cites dilution from $109.2M of notes converted into about 23.2M shares.